In sarcomeres, the low ratio of cMyBP-C to actin likely favors activating effects while minimizing inhibition from competition with myosin heads.
No takes yet. Share an insight, caveat, or question.
May fine-tune sarcomere contractility via cMyBP-C ratios; hypothesis-generating for mechanisms in cardiomyopathy.
Belknap et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: